Corpus Intelligence IC Memo — BEAUMONT BEHAVIORAL HEALTH 2026-04-26 09:38 UTC
IC Memo — BEAUMONT BEHAVIORAL HEALTH
Investment Committee Memorandum | MI | 92 beds | Grade D | EBITDA uplift $1.6M
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

BEAUMONT BEHAVIORAL HEALTH

CCN 234045 | WAYNE, MI | 92 beds | April 26, 2026
EBITDA BridgeData Room
D
Investability

1. Target Overview & Investment Thesis

BEAUMONT BEHAVIORAL HEALTH is a 92-bed community hospital in WAYNE, MI with $21.3M in net patient revenue and a -8.5% operating margin. The hospital serves a payer mix of 6.6% Medicare, 0.0% Medicaid, and 93.4% commercial.

Thesis: Turnaround. Our ML models identify $1.6M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from -8.5% to -1.2% (+736bps).

Net Revenue HCRIS$21.3M
Current EBITDA COMPUTED$-1.8M
Operating Margin COMPUTED-8.5%
Occupancy HCRIS95.3%
Revenue / Bed COMPUTED$232K
Net-to-Gross HCRIS49.5%
Distress Probability MLnan%

2. Market Context & Competitive Position

163
MI Hospitals
-5.2%
State Median Margin
50
Comparable Hospitals

MI has 163 Medicare-certified hospitals with a median operating margin of -5.2%. The target's margin of -8.5% places it below the state median. Among 50 size-comparable peers (46-184 beds), the median margin is -4.6%. The target's below-peer margin suggests operational improvement opportunity.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (46-184), prioritizing same-state peers. 50 hospitals in the comp set.

HospitalStateBedsRevenueMargin
BEAUMONT BEHAVIORAL HEALTH (Target)MI92$21.3M-8.5%
MARQUETTE GENERAL HOSPITALMI163$350.8M-11.5%
KARMANOS CANCER HOSPITALMI106$284.8M-27.8%
ST. MARYS OF MICHIGANMI166$264.2M-32.0%
BRONSON BATTLE CREEKMI144$251.8M-27.7%
ASCENSION PROVIDENCE ROCHESTERMI153$249.9M-4.6%
MYMICHIGAN MEDICAL CENTER ALPEMI128$237.2M6.0%
MCLAREN NORTHERN MICHIGANMI177$235.0M-0.6%
MEMORIAL HEALTHCAREMI113$226.4M-13.4%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $1.6M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$448K+210bp18mo
Cost to Collect4.5%2.5%$427K+200bp12mo
Denial Rate Reduction12.0%6.5%$422K+198bp12mo
A/R Days Reduction5200.0%3800.0%$260K+122bp9mo
Clean Claim Rate88.0%96.0%$14K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$448K
Cost to Collect
$427K
Denial Rate Reduction
$422K
A/R Days Reduction
$260K
Clean Claim Rate
$14K
Total EBITDA Uplift$1.6M
Current EBITDA$-1.8M
+ RCM Uplift+$1.6M
Pro Forma EBITDA$-248K
Current Margin-8.5%
Pro Forma Margin-1.2%
WC Released (1x)$818K

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$-2.8M$3.7M0.00x-100.0%
Base (11x exit)10.0x11.0x$-2.8M$3.2M0.00x-100.0%
Bull Case9.0x11.0x$-2.5M$7.4M0.00x-100.0%
Bull (12x exit)9.0x12.0x$-2.5M$7.4M0.00x-100.0%
Bear Case11.0x10.0x$-3.1M$-3.2M0.00x-100.0%
Bear (11x exit)11.0x11.0x$-3.1M$-4.6M0.00x-100.0%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
HighNegative operating marginRCM uplift bridge shows clear path to profitability; working capital release provides near-term cash cushion

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 50 hospitals with 46-184 beds
  • Same-state prioritization (n=51)
  • Comp margins: P25=-15.8% / P50=-4.6% / P75=1.0%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.